Literature DB >> 33723413

Orphan drug designation and development in Japan: 25 years of experience and assessment.

Ken Sakushima, Hiroshi Takeda, Yoko Aoi.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 33723413     DOI: 10.1038/d41573-021-00045-3

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Nationwide comprehensive epidemiological study of rare diseases in Japan using a health insurance claims database.

Authors:  Kota Ninomiya; Masahiro Okura
Journal:  Orphanet J Rare Dis       Date:  2022-03-28       Impact factor: 4.123

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.